Asthma Control Through Telemedicine

NCT06863285 | Not Yet Recruiting

• 1 other identifier: ABJan012025
• Study Type: interventional
• Target: 140
• Locations: 1 country
• Sites: 1

Brief Summary

The purpose of this research study is to evaluate the impact of pharmacist led educational interventions on Asthmatic patients, and also determine their medication adherence. Pharmacist's intervention aims to answer:

1. 1.How a pharmacist intervention program impact medication adherence in persistent asthma?
2. 2.To assess how pharmacist led educational intervention like patients' counseling and medication reminders through Telemedicine have an impact on patient's asthma control?
3. 3.Which mode of communication (Verbal instructions, videos and pamphlets) for the patient counselling is most beneficial for the patients in asthma control.

Conditions

Asthmatic Patients

Keywords

Asthma; Telemedicine; pharmacist

Outcome Measures

Primary Outcomes (2)

• Asthma Control Score

  Patient health related outcomes that is level of asthma control is measured by pre-validated tool Asthma Control test TM (ACT). The Asthma Control Test™ assess responsiveness to changes in asthma control over time. The tool has 5 questions with each having options with scores 1,2,3,4, and 5. A SCORE OF 19 OR LESS might be a warning of the need for further evaluation to determine whether adjustments to asthma treatment regimens or other measures are required to improve asthma control. If score is 15 or less, asthma may be poorly controlled or not controlled at all.

  1 month

• Patients Medication Adherence Score

  The primary aim of this study will be to evaluate the effectiveness/impact of a pharmacist educational intervention on medication adherence in Asthmatic patients. Adherence will be measured using the adherence to asthma medication questionnaire (AAMQ-13 The AAMQ-13 is a reliable and valid questionnaire with several desirable characteristics as it has a high internal validity, good criterion validity, and strong construct validity. The AAMQ-13 is a suitable questionnaire that can identify non-adherent patients and reveal the reasons behind their non-adherence (intentional or unintentional non-adherence). Each question has Always, Often, sometimes, rarely and never response with scores allotted as 1,2,3,4 and 5 respectively, Score interpretation is as follows for the given tool Poor adherence Score= 13-29 Moderate adherence Score= 30-47 Excellent adherence= 48-65

  1 month

Study Arms (2)

Study group

EXPERIMENTAL

intervention included the usual counselling by pharmacist e.g. Patients Education regarding Medications * Pharmacist counseling patients regarding their disease and severity * Pharmacist counseling (5- to 10-minute sessions) on the proper and safe use of medication. * Pharmacist counseling patients regarding the importance of their therapy (treatment), non-pharmacological treatment like diet and exercises. pharmacist counselling regarding the preventive measures that prevent patient from triggers that can initiate asthmatic attacks.

Other: Educational

Control group

NO INTERVENTION

No intervention

Interventions

Educational OTHER

intervention included the usual counselling by pharmacist e.g. Patients Education regarding Medications * Pharmacist counseling patients regarding their disease and severity * Pharmacist counseling (5- to 10-minute sessions) on the proper and safe use of medication. * Pharmacist counseling patients regarding the importance of their therapy (treatment), non-pharmacological treatment like diet and exercises. pharmacist counselling regarding the preventive measures that prevent patient from triggers that can initiate asthmatic attacks.

Study group

Eligibility Criteria

• Age: 11 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Child (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

• Age above 11 years.
• Persistent Asthma Patient.
• Patients taking medications and inhaler.
• Patient who will consent for the study.
• Patient with basic telecommunication facility.
• Patient who responded to messages and calls.

You may not qualify if:

• Patients who will refuse to participate in study will not be included.
• Irresponsive patients to messages and calls

Sponsors & Collaborators

• Hamdard University: lead

Study Sites (1)

Hamdard University

Islamabad, Punjab Province, 44000, Pakistan

Location

MeSH Terms

Conditions

Asthma

Condition Hierarchy (Ancestors)

Bronchial Diseases; Respiratory Tract Diseases; Lung Diseases, Obstructive; Lung Diseases; Respiratory Hypersensitivity; Hypersensitivity, Immediate; Hypersensitivity; Immune System Diseases

Central Study Contacts

MUhammad Abubakar, PhD

CONTACT

+923237166544; mabubakar.pharmacist@gmail.com

Matti Ullah, PhD

CONTACT

0092-51-8840000; mattiullah@hamdard.edu.ph

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: SINGLE
• Who Masked: PARTICIPANT
• Purpose: SUPPORTIVE CARE
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Assistant professor

Study Record Dates

• First Submitted: March 3, 2025
• First Posted: March 7, 2025
• Study Start: March 20, 2025
• Primary Completion: May 20, 2025
• Study Completion: May 20, 2025
• Last Updated: March 11, 2025

Record last verified: 2025-03

Data Sharing

• IPD Sharing: Will not share

Locations

PA (1)